Cardiomyocytes for Mechanistic Cardiovascular Safety Liabilities
Cardiovascular safety liabilities remain an important concern in drug development that impacts candidate attrition and may lead to adverse clinical events. These liabilities (as evidenced by various oncology drugs) span the spectrum of arrhythmias, contractile dysfunction, myocardial injury and infl (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 17, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

HRS Consensus on Catheter Ablation of Ventricular Arrhythmias HRS Consensus on Catheter Ablation of Ventricular Arrhythmias
The global effort fully updates 2009 recommendations and reflects the rapid progress seen in the field.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 17, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

FDA clears AliveCor's six-lead smartphone ECG
The KardiaMobile 6L builds upon its predecessor with a third electrode placed on its back side, allowing cardiologists better insight into device owners'arrhythmias. (Source: mobihealthnews)
Source: mobihealthnews - May 13, 2019 Category: Information Technology Source Type: news

Stress may cause heart arrhythmia, even without genetic risk
Emotional stress may trigger an irregular heart beat, which can lead to a more serious heart condition later in life, new research shows. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 10, 2019 Category: Consumer Health News Source Type: news

Differential physiological sensitivity to child compliance behaviors in abusing, neglectful, and non-maltreating mothers - Norman Wells J, Skowron EA, Scholtes CM, DeGarmo DS.
We examined time-ordered associations between children's compliance behavior and maternal respiratory sinus arrhythmia (RSA) in a sample of 127 child-maltreating (physical abuse, physical neglect, emotional abuse) and 94 non-maltreating mothers and their p... (Source: SafetyLit)
Source: SafetyLit - May 10, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Treatment to restore natural heartbeat could be on the horizon for heart failure
(University of Chicago Medical Center) A new therapy to re-engage the heart's natural electrical pathways -- instead of bypassing them -- could mean more treatment options for heart failure patients who also suffer from electrical disturbances, such as arrhythmias, according to research led by the University of Chicago Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2019 Category: International Medicine & Public Health Source Type: news

FDA clears Biofourmis' software for ECG-based arrhythmia detection
The RhythmAnalytics platform can integrate with medical devices and other ECG management systems. (Source: mobihealthnews)
Source: mobihealthnews - May 2, 2019 Category: Information Technology Source Type: news

Down the Rabbit Hole: Deciphering the Short QT Syndrome Down the Rabbit Hole: Deciphering the Short QT Syndrome
A newly developed rabbit model reproduces the clinical phenotype of short QT type 1 syndrome, providing a new resource for studies of this inherited arrhythmia syndrome.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 29, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Fitness Linked to Lower Ventricular Arrhythmia Risk Later Fitness Linked to Lower Ventricular Arrhythmia Risk Later
The finding fits with abundant evidence that cardiorespiratory fitness, here measured during exercise tests in men followed for decades, protects against cardiovascular events long-term.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

AliveCor ’s New Indications Help Consumers Understand Their Hearts
AliveCor is giving consumers a chance to understand their heart (beats) a whole better through a pair of new indications. The Mountain View, CA-based company said its KardiaMobile ECG is now cleared for the detection of BradyCardia and TachyCardia. Previously, AliveCor had a nod from FDA for KardiaMobile to detect Atrial Fibrillation (AFib) and Normal Sinus Rhythm. The Mountain View, CA-based company said the new indications make it the only consumer-cleared device with the ability to detect the three most common heart arrhythmias. "No other consumer ECG device in the world, can tell you more about your heart than Kar...
Source: MDDI - April 24, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device
KardiaMobile® Now The Only Personal ECG to Detect The Three Most Common Heart Arrhythmias MOUNTAIN VIEW, Calif., April 23, 2019 -- (Healthcare Sales & Marketing Network) -- AliveCor, the leader in FDA-cleared consumer electrocardiogram technology (... Devices, Monitoring, Cardiology, FDA AliveCor, KardiaMobile, ECG, Bradycardia, Tachycardia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2019 Category: Pharmaceuticals Source Type: news

A case of fatal acebutolol poisoning: an illustration of the potential of molecular networking - Le Dar é B, Allard S, Bouvet R, Baert A, Allard PM, Morel I, Gicquel T.
Acebutolol is a β1-selective adrenergic receptor antagonist with moderate membrane-stabilizing activity and intrinsic sympathomimetic activity; accordingly, the drug is indicated in hypertension, angina pectoris, and arrhythmia. However, acebutolol's beta... (Source: SafetyLit)
Source: SafetyLit - April 22, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Patch Offers a New Approach for Treating Iron Deficiency
Patch-like wearables are becoming increasingly popular in medtech. The latest device to employ such a design and make medtech headlines is transdermal patch being developed by Fe3 Medical. San Antonio, TX-based Fe3 said its biphasic iontophoretic transdermal technology is for the treatment of iron deficiency anemia. The firm announced results from its first human study of the patch-like device. The human study focused on the safety and tolerability of Fe3's iontophoretic transdermal technology designed to bypass ionic resistance build up in the skin. The human study follows a series of successful preclinical studies demons...
Source: MDDI - April 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Adhesives Source Type: news

Thai Cave Rescue: Details for Preventing Hypothermia, Panic Thai Cave Rescue: Details for Preventing Hypothermia, Panic
The medical team sedated the boys with ketamine to prevent the boys'panic and reduce concerns about arrhythmia or medication-related drops in body temperature.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 3, 2019 Category: Emergency Medicine Tags: Emergency Medicine News Source Type: news

Computer Model Predicts Risk for Ventricular Arrythmia in ARVC
WEDNESDAY, April 3, 2019 -- A new model can predict the risk for incident ventricular arrhythmias (VAs) in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC), according to a study published online March 27 in the European... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 3, 2019 Category: Pharmaceuticals Source Type: news

BioSig raises $9m
BioSig Technologies (OTCQB: BSGM) has raised $8.6 million in a new round of equity financing, according to a recently posed SEC filing. The Santa Monica, Calif.-based company is developing the Pure EP system, which is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. The device is intended to reduce noise and artifacts to produce high-fidelity cardiac signals, which the company claims could increase the diagnostic values of the signals. BioSig is...
Source: Mass Device - March 29, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat BioSig Technologies Source Type: news

Fetal nicotine exposure linked to SIDS
Pregnant women who smoke may be raising the risk of their newborn having sudden infant death syndrome or heart arrhythmia, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 28, 2019 Category: Consumer Health News Source Type: news

Novel study links fetal exposure to nicotine and sudden infant death syndrome
(Elsevier) Fetal exposure to tobacco smoke in utero is associated with sudden infant death syndrome (SIDS) and cardiac arrhythmias in newborns. In a novel study in rabbits, investigators provide the first evidence linking fetal exposure to nicotine to long-term alterations of the cardiac sodium current. These changes may impair adaptation of the cardiac sodium current to sympathetic tone and prevent awakening from sleep apnea, leading to arrhythmias that could potentially be involved in SIDS. They report their findings in HeartRhythm (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 28, 2019 Category: International Medicine & Public Health Source Type: news

Atrial Arrhythmias in Takotsubo Syndrome Atrial Arrhythmias in Takotsubo Syndrome
Inflammation may be a predictor for new onset atrial arrhythmias in Takotsubo cardiomyopathy.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Detecting Arrhythmias in Clinical Trials Using ECG Monitoring, New...
Clinical trials in cardiovascular medicine have grown in size, scope and complexity, requiring instruments for monitoring the heart to keep pace. Electrocardiographic (ECG) monitoring has evolved from...(PRWeb March 21, 2019)Read the full story at https://www.prweb.com/releases/detecting_arrhythmias_in_clinical_trials_using_ecg_monitoring_new_webinar_hosted_by_xtalks/prweb16185858.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 21, 2019 Category: Pharmaceuticals Source Type: news

Boston Scientific touts Luminize catheter study
Boston Scientific (NYSE:BSX) this week touted results from a study of a single-shot ablation catheter for atrial fibrillation at a European cardiac rhythm conference. The Marlborough, Mass.-based medical device giant said the 100-patient AF-ficient I study of intermittent AF proceeded in two stages. Phase one, testing the original Luminize design, showed a pulmonary vein isolation rate of 88.9%; phase two, testing enhanced steering and electrodes, showed a PV isolation rate of 99.4%. The median balloon dwell time dropped from 92 minutes in the first phase to 29 minutes in the second, bringing total procedure time down...
Source: Mass Device - March 19, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Clinical Trials Featured Boston Scientific Cardiac Rhythm Management Source Type: news

Should You Get Pills or Surgery for A-Fib?
Study subjects who got ablation -- where a catheter is used to tweak the heart muscle cells responsible for the arrhythmia -- also seemed to have less shortness of breath, less fatigue and all-around better quality of life five years later, with those who got drug therapy alone. (Source: WebMD Health)
Source: WebMD Health - March 15, 2019 Category: Consumer Health News Source Type: news

Biotronik wins FDA nod for Acticor, Rivacor high-voltage tachycardia devices
Biotronik said yesterday it won FDA approval for its Acticor and Rivacor high-voltage cardiac rhythm management devices intended for treating patients with cardiac arrhythmias. The clearance covers the Berlin, Germany based company’s Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX Bipolar and Acticor CRT-DX devices. “When determining the best treatment plan for each patient, we assess individual needs and select a device system that provides optimal therapy programming with critical diagnostic features. We are often forced to choose between important features, which could compromise opti...
Source: Mass Device - March 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Featured Food & Drug Administration (FDA) Regulatory/Compliance Biotronik Source Type: news

Heart procedure for AFib better than drug therapy for reducing episodes
ROCHESTER, Minn. -- Atrial fibrillation is a common arrhythmia that affects an estimated 30 million people worldwide. New research shows that catheter ablation, a common cardiovascular procedure, appears no more effective than drug therapy to prevent strokes, deaths and other complications in patients with atrial fibrillation. But patients who receive catheter ablation experience much greater [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - March 15, 2019 Category: Research Source Type: news

A Push for Push Dose Epinephrine
You transport a 79-year-old woman to the hospital for fever and urinary incontinence. Her family mentions a history of frequent urinary tract infections. Her initial vital signs are a heart rate of 115 bpm, an oxygen saturation of 97% on room air, and a blood pressure of 105/75 mmHg. You establish a peripheral IV line and begin a bolus of normal saline. About 15 minutes away from the hospital, you note the patient becomes increasingly drowsy. Her heart rate has increased to 125 bpm and her blood pressure is now 85/47 mmHg. What are your next steps? Prehospital Shock Starting in 2018, push dose epinephrine replaced dopamine...
Source: JEMS Patient Care - March 14, 2019 Category: Emergency Medicine Authors: Sammy Hodroge, MD Tags: Training Cardiac & Resuscitation Top Story Exclusive Articles Patient Care Source Type: news

Getting specific about emotion and self-inflicted injury: an examination across emotion processes in borderline personality disorder - Fitzpatrick S, Zeifman R, Krantz L, McMain S, Kuo JR.
This study aimed to examine which specific emotion processes influence self-inflicted injury: basal respiratory sinus arrhythmia, baseline negative emotional intensity, emotional reactivity, or emotion regulation deficits. METHOD: Self-i... (Source: SafetyLit)
Source: SafetyLit - March 13, 2019 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Sotera Wireless adds tools to patient monitoring system
Sotera Wireless said it has upgraded its ViSi Mobile patient monitoring system to detect atrial fibrillation, ventricular fibrillation and ventricular tachycardia, and to provide asystole analysis. Often asymptomatic, atrial fibrillation may remain undiagnosed until or even after the development of complications, such as stroke. Post-operative atrial fibrillation is the most common arrhythmia that occurs after both cardiac and noncardiac surgery and is associated with increased morbidity, longer hospital stays and higher hospital costs. ViSi Mobile was previously FDA-cleared to monitor continuous noninvasive blood pressure...
Source: Mass Device - March 6, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: 510(k) Blog Food & Drug Administration (FDA) Health Information Technology mHealth (Mobile Health) News Well Patient Monitoring Regulatory/Compliance Sotera Wireless Source Type: news

AliveCor ’s KardiaMobile five times more effective at detecting heart arrhythmia than standard tests in new study
Researchers have now called for the device to be incorporated into standard care in A&E departments. (Source: mobihealthnews)
Source: mobihealthnews - March 4, 2019 Category: Information Technology Source Type: news

Biotronik Has a New DES Added to its Repertoire
FDA has just signed off on Biotronik’s Orsiro drug-eluting stent (System). The Lake Oswego, OR-based company claims the stent is the first and ultrathin DES to outperform Abbott Laboratories’, Xience stent, which is known as the clinical standard. Biotronik said its first implants will occur this week and that it will be available in health systems in the early part of this year. The company has had CE mark for Orsiro since 2011. Perhaps the biggest selling point of the technology is the ultrathin strut design. “Thinner struts are different in that they potentially crea...
Source: MDDI - February 25, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

What Is the Most Common Type of Cardiomyopathy?
Discussion Barth syndrome is characterized by a dilated cardiomyopathy, proximal skeletal muscle weakness, neutropenia and short stature that usually presents at birth or soon after. It is a rare X-linked recessive disease process caused by mutations in the TAZ gene. The TAZ gene codes for tafazzin which alters cardiolipin in mitochondria. Characteristic facies can be seen especially in infancy including a tall and broad forehead, prominent chin and full cheeks, larger ears, and deep-set eyes. Most patients present at birth or soon afterwards but some may not until later in life. Life expectancy is reduced with many childr...
Source: PediatricEducation.org - February 25, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Risk of cardiac arrhythmias after electrical accident: a single-center study of 480 patients - Pilecky D, Vamos M, Bogyi P, Muk B, Stauder D, Racz H, Nyolczas N, Duray GZ, Zacher G, Zima E.
OBJECTIVE: Patients with electrical injury are considered to be at high risk of cardiac arrhythmias. Due to the small number of studies, there is no widely accepted guideline regarding the risk assessment and management of arrhythmic complications after el... (Source: SafetyLit)
Source: SafetyLit - February 18, 2019 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

These medtech companies raised the most VC in 2018
[Image from unsplash.com]Venture capital firms invested more than $2.9 billion in medical device companies in 2018 — a slight increase from the $2.8 billion raised in 2017, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Both the first and second quarters of 2018 saw an increase in investments, totaling nearly $778 million and $786 million respectively. The third and fourth quarters were slightly lower, with medtech companies raising $738 million in Q3 and nearly $641 million in Q4. There were 218 deals in 2018, a slight decrease from the 229 deals involving me...
Source: Mass Device - February 15, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News venture capital Source Type: news

Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients
Patients with syncope who present to the emergency department and who are at low risk for serious arrhythmia can be discharged home after 2 hours of electrocardiogram monitoring, new data show.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 13, 2019 Category: Cardiology Tags: Emergency Medicine News Source Type: news

RSA reactivity in response to viewing bullying film and adolescent social adjustment - Cui L, Zhang X, Houltberg BJ, Criss MM, Morris AS.
This study assessed adolescent respiratory sinus arrhythmia (RSA) reactivity while watching a bullying film clip from Boyz'n the Hood. We emphasized the importance of considering measurement context of RSA and examined whether RSA reactivity moderated the ... (Source: SafetyLit)
Source: SafetyLit - February 13, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Underutilized cardiac MRI stress test predicts mortality
A stress test with cardiac MRI can do more than simply assess heart function....Read more on AuntMinnie.comRelated Reading: SPECT, MRI together advance arrhythmia treatment Imaging modalities differ in assessing key heart metric New protocol enables faster, cheaper cardiac MRI scans Cardiac MRI offers prognosis for hard-to-find infarctions MRI technique could let cardiac patients breathe easier (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2019 Category: Radiology Source Type: news

Acutus ‘Uncovers’ AcQMap’s Effectiveness with Trial Data
Data from the UNCOVER-AF trial reinforces the effectiveness of Acutus Medical’s AcQMap Imaging System in persistent atrial fibrillation (AF) ablation procedures. The Carlsbad, CA-based company released the data in late January at the 24th annual AF Symposium in Boston. AcQMap is a technology that combines charge mapping and high-resolution ultrasound imaging to create animated, 3D images in seconds that display anatomy and atrial arrhythmias. In the UNCOVER AF trial, investigators used AcQMap and a variety of on-market ablation technologies, to treat a total of 127 patients with de novo, persistent AF at...
Source: MDDI - February 6, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Imaging Source Type: news

J & J ’ s Biosense Webster launches IDE-cleared Qdot Micro RF ablation trial
Johnson & Johnson‘s (NYSE:JNJ) Biosense Webster said yesterday it launched a new FDA investigational device exemption study of its Qdot Micro radiofrequency ablation catheter exploring its use in treating symptomatic drug-refractory paroxysmal atrial fibrillation. The first patient in the trial has already been treated, with the procedure taking place at NYU Langone Health’s Heart Rhythm Center, the Irvine, Calif.-based J&J division said. “The delivery of 90 watts of RF power in a short, four-second ablation session is a significant advancement in the treatment of paroxysmal atrial fibri...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Food & Drug Administration (FDA) johnsonandjohnson Source Type: news

SPECT, MRI together advance arrhythmia treatment
The combination of information from cardiac MRI and iodine-123 metaiodobenzylguanidine...Read more on AuntMinnie.comRelated Reading: Augmented reality primed for MR-guided cardiac ablation 3D virtual heart helps pinpoint irregular heartbeat Imaging modalities differ in assessing key heart metric New protocol enables faster, cheaper cardiac MRI scans ASNC releases new guidelines for SPECT MPI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2019 Category: Radiology Source Type: news

Acutus Medical touts 12-month AcQMap-guided AF ablation trial data
Acutus Medical today released 12-month data from the Uncover-AF trial of its AcQMap cardiac imaging and mapping system exploring its use in persistent atrial fibrillation ablation procedures. Results from the trial were presented at the 24th Annual AF Symposium in Boston, the Carlsbad, Calif.-based company said. Acutus Medical’s AcQMap system is designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound. “We have mapped arrhythmias with the same technology for decades without asking if th...
Source: Mass Device - January 29, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Acutus Medical Source Type: news

Myocardial infarction following a blunt chest trauma: a case report - Li X, Wang Z, Yang Y, Meng F, He Y, Yang P.
RATIONALE: Blunt cardiac injury (BCI) is a common complication after blunt chest trauma, which can lead to mild arrhythmia, severe chamber or valvular rupture, or even death. Myocardial infarction following blunt chest trauma is a rare but fatal condition.... (Source: SafetyLit)
Source: SafetyLit - January 29, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Study uncovers why heart attack triggers arrhythmia in some, explores potential treatment
(University of California - San Diego) A team of researchers led by the University of California San Diego has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm, or arrhythmia, after experiencing a heart attack. They have also identified a drug candidate that can block this pathway. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2019 Category: International Medicine & Public Health Source Type: news

Prolonged QT syndrome due to donepezil: a reversible cause of falls? - Jackson EG, Stowe S.
We report a case of prolonged QT syndrome caused by donepezil which resulted in a fall and hip fracture. In this case... (Source: SafetyLit)
Source: SafetyLit - January 21, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Alcohol and the Electric Atrium: How Drinking Promotes AF? Alcohol and the Electric Atrium: How Drinking Promotes AF?
Electrophysiologic studies are helping define the nature of atrial fibrillation's myocardial remodeling effects in moderate drinkers with the arrhythmia.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 18, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Lightning skin burns: a case report - Abdelraouf T, ElHafez M, Elmorsy E.
This study presents a report on a 50-y... (Source: SafetyLit)
Source: SafetyLit - January 15, 2019 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Machine Matches Docs for Arrhythmia Detection
(MedPage Today) -- Investigators said rare instances of VT misclassification were'very reasonable'(Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 9, 2019 Category: Cardiology Source Type: news

iRhythm Finds Its Groove at the Intersection of Cardiology and AI
iRhythm Technologies has the distinct feature of being at the intersection of some of the hottest markets in medtech – cardiology, wearables, and artificial intelligence. The San Francisco-based company has developed, the Zio Patch XT, a wearable technology to monitor heart rate activity for up to 14 days and is set to present at the 37th Annual J.P. Morgan Healthcare Conference this week. Tim King, iRhythm’s president and CEO spoke to MD+DI ahead of the company’s presentation about the company's success and its goals going forward. “The tool of choice...
Source: MDDI - January 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Digital Health Source Type: news

Stanford, iRhythm's deep neural network matches cardiologists at arrhythmia classification
An algorithm trained on a deep neural network was able to perform on par with board certified cardiologist when annotating 12 different types of hearth rhythms.   (Source: mobihealthnews)
Source: mobihealthnews - January 6, 2019 Category: Information Technology Source Type: news

New Apple Watch OK'd for Arrhythmia Detection
(MedPage Today) -- Single-lead electrocardiogram built into latest version cleared by FDA (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 28, 2018 Category: American Health Source Type: news

New study shows link between secondhand smoke and cardiac arrhythmia
(University of California - Davis Health) Continuous indoor exposure to secondhand tobacco smoke triggers changes in the heart's electrical activity, known as cardiac alternans, that can predict cardiac arrhythmia and sudden cardiac death, a new study from UC Davis Health researchers shows. The authors believe the study, conducted in mice, suggests that secondhand smoke exposure alters cells that regulate how the heart beats. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2018 Category: International Medicine & Public Health Source Type: news